|

ISPOR Quality Improvement in Cost Effectiveness Research Task Force
TASK FORCE CHAIR:
William McGhan, PharmD, PhD, Professor of Pharmacy and Health
Policy, University of the Sciences, Philadelphia, PA, USA
TASK FORCE GROUP:
Maiwenn Al, PhD, Senior Research Fellow, institute for Medical Technology Assessment (iMTA), Erasmus MC, Rotterdam, Netherlands
Jalpa Doshi, PhD, Professor of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Isao Kamae, MD, DrPH, Professor of Applied Medical Statistics and Decision Sciences, Kobe University, Kobe, Japan
Steven E. Marx, PharmD, MS, Associate Director, Global Pharmaceutical Research & Development, Abbott Laboratories, Chicago, IL, USA
Donna Rindress, PhD, President & Managing Director, BioMedCom Consultants, Inc., Montreal, Quebec, Canada
BACKGROUND:
While the average health care researcher or practitioner may be
able to follow major health care economic indicators and the
release of major health care economic studies, a process to
track overall quality of health care economic studies and their
use in making health care policies is needed. Reviews and
periodic quality reports advance international health care
efficiency and quality and become a mainstay of our global
effort to improve the economics and quality of life in all
health care sectors.
Methods and statistics used in health
care economic studies need to be critiqued periodically to
improve the quality and usefulness for these studies and
guidelines. It is also important to monitor the quality of
health care economic study guidelines being used by journals,
organizations and governments around the world for assessing new
therapies and allocation of resources.
For more information, see:
QUALITY IMPROVEMENT OF HEALTH CARE ECONOMIC EVALUATION RESEARCH AND USE IN HEALTH CARE POLICY
MISSION:
The mission of the ISPOR Quality Improvement in Cost Effectiveness Research (QICER) Task Force* and Its Use in Making
Health Care Policy (through surveys, white papers, and sessions
at ISPOR meetings) is to report and facilitate the improvement
of health care economic evaluation research and its use in
making health care policy.
The specific tasks are to:
- Develop periodic reports on the state and quality of health
care economic evaluations and use of these studies in making
health care policy
- Develop recognition of good health care economic evaluation
research
- Develop a repository of ‘reference cases’ for health care
economic evaluation research
- Develop a report card on the quality of journal guidelines on
health care economic evaluations as well as government
guidelines on health care economic evaluation information
*Health care economic evaluation research includes: budget
impact analysis, cost-benefit analysis,
cost-effectiveness analysis, cost-efficiency analysis,
cost-consequence, cost-minimization analysis,
cost-utility analysis, cost of illness, and cost of
treatment studies
|